Re: Sadiq et al.: Effect of vitreomacular adhesion on treatment outcomes in the ranibizumab for edema of the macula in diabetes (READ-3) study (Ophthalmology 2016; 123: 324-329) Reply

被引：0
|
作者：
Sadiq, Mohammad Ali [1 ]
Quan Dong Nguyen [1 ]
Sepah, Yasir Jamal [1 ]
机构：
[1] Ocular Imaging Res & Reading Ctr, Omaha, NE 68198 USA
来源：
OPHTHALMOLOGY | 2017年 / 124卷 / 01期
关键词：
D O I：
10.1016/j.ophtha.2016.05.015
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：E13 / E13
页数：1
相关论文
共 12 条
  • [1] Re: Sadiq et al.: Effect of vitreomacular adhesion on treatment outcomes in the ranibizumab for edema of the macula in diabetes (READ-3) study (Ophthalmology 2016; 123: 324-329)
    Azad, Shorya
    Takkar, Brijesh
    OPHTHALMOLOGY, 2017, 124 (01) : E12 - E13
  • [2] Effect of Vitreomacular Adhesion on Treatment Outcomes in the Ranibizumab for Edema of the Macula in Diabetes (READ-3) Study
    Do, Diana
    Quan Dong Nguyen
    OPHTHALMOLOGICA, 2016, 236 : 8 - 8
  • [3] Effect of Vitreomacular Adhesion on Treatment Outcomes in the Ranibizumab for Edema of the Macula in Diabetes (READ-3) Study
    Sadiq, Mohammad Ali
    Soliman, Mohamed Kamel
    Sarwar, Salman
    Agarwal, Aniruddha
    Hanout, Mostafa
    Demirel, Sibel
    Rentiya, Zubir S.
    Khan, Waqar
    Do, Diana V.
    Quan Dong Nguyen
    Sepah, Yasir J.
    OPHTHALMOLOGY, 2016, 123 (02) : 324 - 329
  • [4] Effect of Vitreomacular Adhesion on Treatment Outcomes in the Ranibizumab for Edema of the Macula in Diabetes-3 (READ-3) Study
    Sepah, Yasir
    Quan Nguyen
    OPHTHALMOLOGICA, 2016, 236 : 42 - 42
  • [5] Effect of Vitreomacular Adhesion on Treatment Outcomes in the Ranibizumab for Edema of the mAcula in Diabetes-3 (READ-3) Study
    Sadiq, Mohammad Ali
    Soliman, Mohamed Kamel
    Hanout, Mostafa Saad
    Sarwar, Salman
    Agarwal, Aniruddha
    High, Robin
    Do, Diana V.
    Quan Dong Nguyen
    Sepah, Yasir Jamal
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [6] Effect of Vitreomacular Adhesion on Treatment Outcomes in the Ranibizumab for Edema of the mAcula in Diabetes-3 (READ-3) Study -Month 24 Results
    Sadiq, Mohammad Ali
    Hassan, Muhammad
    Afridi, Rubbia
    Halim, Muhammad Sohail
    Do, Diana V.
    Quan Dong Nguyen
    Sepah, Yasir Jamal Jamal
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [7] Re: Wells et al.: Aflibercept, Bevacizumab, or Ranibizumab for diabetic macular edema: Two-year results from a comparative effectiveness randomized clinical trial (Ophthalmology 2016;123:1351-1358) Reply
    Wells, John A.
    Glassman, Adam R.
    Jampol, Lee M.
    Ayala, Allison
    Bressler, Neil M.
    OPHTHALMOLOGY, 2017, 124 (03) : E26 - E27
  • [8] Re: Chu et al.: Risk factors and incidence of macular edema after cataract surgery: a database study of 81 984 eyes (Ophthalmology 2016;123:316-323) REPLY
    Chu, Colin J.
    Johnston, Robert L.
    Buscombe, Charlotte
    Sallam, Ahmed B.
    Mohamed, Quresh
    Yang, Yit C.
    OPHTHALMOLOGY, 2017, 124 (02) : E17 - E18
  • [9] Re: Slidsborg et al.: Neonatal risk factors for treatment-demanding retinopathy of prematurity: a Danish national study (Ophthalmology 2016;123:796-803) REPLY
    Slidsborg, Carina
    Jensen, Aksel
    Forman, Julie Lyng
    Rasmussen, Steen
    Bangsgaard, Regitze
    Fledelius, Hans Callo
    Greisen, Gorm
    de la Cour, Morten
    OPHTHALMOLOGY, 2016, 123 (12) : E73 - E73
  • [10] Re: Whitman et al.: Treatment of presbyopia in emmetropes using a shape-changing corneal inlay: one-year clinical outcomes (Ophthalmology 2016;123:466-75) REPLY
    Whitman, Jeffrey
    OPHTHALMOLOGY, 2016, 123 (12) : E72 - E72
12